Biotech and Pharma Sectors Decline as Investor Capital Rotates Into Energy Barrons Analysis TDW Q1 2026 Earnings Wide EPS Miss Underscores Operational Headwinds FTSE Russell Survey Affluent Investors Heavily Rely on Advisors for Private Market Allocations